Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drucker

Showing results (41-50 of 549) with videos related to

Pageof 55
Sort By:
Endocrine Pathology|March 7, 2020
Parathyroid hormone-like peptideDaniel J Drucker
Diabetes Care|June 6, 2024
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and ObesityDaniel J Drucker
History of the Human Sciences|September 23, 2016
‘A most interesting chapter in the history of science’ intellectual responses to Alfred Kinsey’s Sexual Behavior in the Human MaleDonna J Drucker
Cell Metabolism|September 15, 2016
Never Waste a Good Crisis: Confronting Reproducibility in Translational ResearchDaniel J Drucker
The American Journal of Physiology|November 1, 1994
Molecular pathophysiology of glucagon-SV40 T antigen transgenic miceD J Drucker
Current Urology Reports|June 27, 2002
Prognostic factors for biologic therapy in kidney cancerBeverly J Drucker
Dental Economics - Oral Hygiene|June 1, 1988
How to retire at age 55D J Drucker
Diabetologia|February 7, 2021
Transforming type 1 diabetes: the next wave of innovationDaniel J Drucker
The Diabetes Educator|March 24, 2006
Incretin-based therapies: a clinical need filled by unique metabolic effectsDaniel J Drucker
The New England Journal of Medicine|September 19, 2024
Discovery of GLP-1-Based Drugs for the Treatment of ObesityDaniel J Drucker
Pageof 55

Showing results (41-50 of 549) with videos related to

Sort By:
Pageof 55
Endocrine Pathology|March 7, 2020
Parathyroid hormone-like peptideDaniel J Drucker
Diabetes Care|June 6, 2024
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and ObesityDaniel J Drucker
History of the Human Sciences|September 23, 2016
‘A most interesting chapter in the history of science’ intellectual responses to Alfred Kinsey’s Sexual Behavior in the Human MaleDonna J Drucker
Cell Metabolism|September 15, 2016
Never Waste a Good Crisis: Confronting Reproducibility in Translational ResearchDaniel J Drucker
The American Journal of Physiology|November 1, 1994
Molecular pathophysiology of glucagon-SV40 T antigen transgenic miceD J Drucker
Current Urology Reports|June 27, 2002
Prognostic factors for biologic therapy in kidney cancerBeverly J Drucker
Dental Economics - Oral Hygiene|June 1, 1988
How to retire at age 55D J Drucker
Diabetologia|February 7, 2021
Transforming type 1 diabetes: the next wave of innovationDaniel J Drucker
The Diabetes Educator|March 24, 2006
Incretin-based therapies: a clinical need filled by unique metabolic effectsDaniel J Drucker
The New England Journal of Medicine|September 19, 2024
Discovery of GLP-1-Based Drugs for the Treatment of ObesityDaniel J Drucker
Pageof 55